Glazer Capital »

Terns Pharmaceuticals shares owned by Glazer Capital

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Glazer Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $121M 2.3M 52.72

More positions owned by Glazer Capital

Air Lease Corp Cl A
Hologic
Sealed Air
Clearwater Analytics Hldgs I Cl A (CWAN)
Amicus Therapeutics (FOLD)
Onestream Cl A
Arcellx Common Stock (ACLX)
Brighthouse Finl (BHF)
Digitalbridge Group Cl A New (DBRG)
Terns Pharmaceuticals (TERN)
Tri Pointe Homes (TPH)
Day One Biopharmaceuticals I (DAWN)
Electronic Arts (EA)
Semrush Hldgs Cl A Com (SEMR)
Select Medical Holdings Corporation (SEM)

View all positions for Glazer Capital

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals